{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-26-000531","form_type":"8-K","ticker":"ZPTA","cik":"0001843714","company_name":"Zapata Quantum, Inc.","filed_at":"2026-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.105445+00:00","generated_at":"2026-05-15T04:13:57.115148+00:00","sec_items":["3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Zapata Quantum completes oversubscribed $15M financing led by Triatomic Capital","bullets":["$15M oversubscribed round led by Triatomic Capital; other strategic investors participated.","Financing marks final milestone of year-long restructuring; capital to scale platform and team.","Funds to be used to expand science, engineering, product, and commercial functions.","Company highlights quantum-enabled drug discovery research named Nature Biotechnology cover paper in Dec 2025.","Zapata focuses on hardware-agnostic quantum software, closing gap from experimentation to production."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-26-000531","json":"https://secwatch.observer/filing/0001079973-26-000531.json","markdown":"https://secwatch.observer/filing/0001079973-26-000531.md","text":"https://secwatch.observer/filing/0001079973-26-000531.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1843714/000107997326000531/0001079973-26-000531-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1843714/000107997326000531/zapata_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:13:57.115148+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}